Outcomes of Psychoeducation Combined with a Text Messaging Adherence Intervention in Individuals with Hypertension and Bipolar Disorder

Objective: This study evaluated the feasibility, acceptability, and preliminary efficacy of psychoeducation plus an automated text-messaging intervention (iTAB-CV) to improve adherence for antihypertensives and bipolar disorder medication. Methods: Following a psychoeducation program, iTAB-CV was administered for two months. In month one, participants received one educational/motivational and one mood rating text daily. In month two, medication reminders were added. Results: The sample (n=38) was 74% African-Americans, 53% women, with a mean age of 51.53±9.06. Antihypertensive non-adherence decreased from 43%±23% to 21%±26% at 12 weeks [χ2 = 34.6, df= 3, p< 0.001]. SBP decreased from 144.8±15.5 mmHg to 136.0±17.8 mmHg (χ2 = 17.6, df=3, p< 0.001). Retention was 100%. Conclusions: In this uncontrolled trial, participants were highly engaged and medication adherence and reduced SBP were sustained following psychoeducation plus iTAB-CV. Since iTAB-CV is automated and delivered remotely, it has potential to reach a large and challenging population. Address Correspondence to: Jennifer B. Levin, Ph.D., Department of Psychiatry, University Hospitals Cleveland Medical Center, 10524 Euclid Avenue, Cleveland, Ohio, 44106, Tel: 216-844-5057, Fax: 216-844-1703, Jennifer.levin@uhhospitals.org. All other others have no conflicts of interest to disclose. NCT Clinicaltrials.gov ID: NCT02983877 HHS Public Access Author manuscript Psychiatr Serv. Author manuscript; available in PMC 2020 July 01. Published in final edited form as: Psychiatr Serv. 2019 July 01; 70(7): 608–612. doi:10.1176/appi.ps.201800482. A uhor M anscript

[1]  C. Depp,et al.  Patient Participation in the Development of a Customized M-Health Intervention to Improve Medication Adherence in Poorly Adherent Individuals with Bipolar Disorder (BD) and Hypertension (HTN). , 2018, International journal of healthcare.

[2]  M. Sajatovic,et al.  Medication Adherence in Patients with Bipolar Disorder: A Comprehensive Review , 2016, CNS Drugs.

[3]  M. Woodward,et al.  Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis. , 2016, JAMA internal medicine.

[4]  Jessica L. Montoya,et al.  Individualized Texting for Adherence Building (iTAB): Improving Antiretroviral Dose Timing Among HIV-Infected Persons with Co-occurring Bipolar Disorder , 2015, AIDS and Behavior.

[5]  A. Valderrama,et al.  Racial/Ethnic Disparities in the Awareness, Treatment, and Control of Hypertension — United States, 2003–2010 , 2013, MMWR. Morbidity and mortality weekly report.

[6]  J. Fiedorowicz,et al.  Cardiovascular morbidity and mortality in bipolar disorder. , 2011, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[7]  Alan Shafer,et al.  Meta-analysis of the brief psychiatric rating scale factor structure. , 2005, Psychological assessment.

[8]  B. Verplanken,et al.  Reflections on past behavior: A self-report index of habit strength , 2003 .

[9]  Jan Scott,et al.  Nonadherence with mood stabilizers: prevalence and predictors. , 2002, The Journal of clinical psychiatry.

[10]  Aart N. Mudde,et al.  Predicting stage transitions for smoking cessation applying the attitude-social influence-efficacy model , 1998 .

[11]  M. Åsberg,et al.  A New Depression Scale Designed to be Sensitive to Change , 1979, British Journal of Psychiatry.

[12]  R. C. Young,et al.  A Rating Scale for Mania: Reliability, Validity and Sensitivity , 1978, British Journal of Psychiatry.

[13]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[14]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.